Comparative analysis of combined methylene blue photodynamic therapy and doxorubicin treatment of oral squamous cell carcinoma cell line: In vitro study on apoptosis

Introduction: Squamous cell carcinoma (SCC) is the most common malignancy of the head and neck region. Combination therapy potentially enhances the effectiveness beyond that of each treatment alone. This study aimed to assess whether photodynamic therapy (PDT), using methylene blue as a photosensiti...

Full description

Saved in:
Bibliographic Details
Main Authors: Shayan Momeni Goujani, Maryam Koopaie, Fateme Hamta Safarian, Neda Hakimiha, Shima Younespour
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Photodiagnosis and Photodynamic Therapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1572100024004939
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832575551718555648
author Shayan Momeni Goujani
Maryam Koopaie
Fateme Hamta Safarian
Neda Hakimiha
Shima Younespour
author_facet Shayan Momeni Goujani
Maryam Koopaie
Fateme Hamta Safarian
Neda Hakimiha
Shima Younespour
author_sort Shayan Momeni Goujani
collection DOAJ
description Introduction: Squamous cell carcinoma (SCC) is the most common malignancy of the head and neck region. Combination therapy potentially enhances the effectiveness beyond that of each treatment alone. This study aimed to assess whether photodynamic therapy (PDT), using methylene blue as a photosensitizer in conjunction with doxorubicin, produces synergistic effects on the apoptosis of the oral squamous cell carcinoma (OSCC) cell line. Materials and methods: The human oral epidermal carcinoma cell line (KB cell line, NCBI Code: C152) was cultured in Dulbecco's modified Eagle's medium. Following at least 24 hours of incubation, the OSCC cells were distributed into six groups, with groups 1–3 and 5 performed in the dark to prevent any light interference. 1: control group; 2: treated with 3.2 μg/mL methylene blue; 3: exposed to various concentrations of doxorubicin; 4: PDT group (methylene blue + 660 nm light); 5: treated with both doxorubicin and methylene blue; and finally, 6: treated with PDT (methylene blue + 660 nm light) in conjunction with doxorubicin. Flow cytometry methods were used to assess apoptosis. Analysis of variance (ANOVA) was used to compare quantitative variables between groups, and Tukey's test was applied for pairwise group comparisons. Results: Flow cytometry analysis revealed that the highest level of cellular apoptosis occurred in the group treated with PDT in conjunction with doxorubicin. Conclusions: PDT using the photosensitizer methylene blue, in combination with doxorubicin, can serve as an effective agent for inducing apoptosis in OSCC cells.
format Article
id doaj-art-dbc3ac70bc4b47a897f0ea315cee5804
institution Kabale University
issn 1572-1000
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Photodiagnosis and Photodynamic Therapy
spelling doaj-art-dbc3ac70bc4b47a897f0ea315cee58042025-02-01T04:11:47ZengElsevierPhotodiagnosis and Photodynamic Therapy1572-10002025-02-0151104457Comparative analysis of combined methylene blue photodynamic therapy and doxorubicin treatment of oral squamous cell carcinoma cell line: In vitro study on apoptosisShayan Momeni Goujani0Maryam Koopaie1Fateme Hamta Safarian2Neda Hakimiha3Shima Younespour4Department of Oral Medicine, School of Dentistry, Tehran University of Medical Sciences, Tehran, IranDepartment of Oral Medicine, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran; Correspondence author at Department of Oral Medicine, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran North Kargar St, Po. Code: 14399-55991 P.O.BOX:14395 -433Department of Oral Medicine, School of Dentistry, Tehran University of Medical Sciences, Tehran, IranLaser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IranDentistry Research Institute, Tehran University of Medical Sciences, Tehran, IranIntroduction: Squamous cell carcinoma (SCC) is the most common malignancy of the head and neck region. Combination therapy potentially enhances the effectiveness beyond that of each treatment alone. This study aimed to assess whether photodynamic therapy (PDT), using methylene blue as a photosensitizer in conjunction with doxorubicin, produces synergistic effects on the apoptosis of the oral squamous cell carcinoma (OSCC) cell line. Materials and methods: The human oral epidermal carcinoma cell line (KB cell line, NCBI Code: C152) was cultured in Dulbecco's modified Eagle's medium. Following at least 24 hours of incubation, the OSCC cells were distributed into six groups, with groups 1–3 and 5 performed in the dark to prevent any light interference. 1: control group; 2: treated with 3.2 μg/mL methylene blue; 3: exposed to various concentrations of doxorubicin; 4: PDT group (methylene blue + 660 nm light); 5: treated with both doxorubicin and methylene blue; and finally, 6: treated with PDT (methylene blue + 660 nm light) in conjunction with doxorubicin. Flow cytometry methods were used to assess apoptosis. Analysis of variance (ANOVA) was used to compare quantitative variables between groups, and Tukey's test was applied for pairwise group comparisons. Results: Flow cytometry analysis revealed that the highest level of cellular apoptosis occurred in the group treated with PDT in conjunction with doxorubicin. Conclusions: PDT using the photosensitizer methylene blue, in combination with doxorubicin, can serve as an effective agent for inducing apoptosis in OSCC cells.http://www.sciencedirect.com/science/article/pii/S1572100024004939Oral squamous cell carcinomaPhotodynamic therapyDoxorubicinMethylene blueApoptosisSquamous cell carcinoma of the head and neck
spellingShingle Shayan Momeni Goujani
Maryam Koopaie
Fateme Hamta Safarian
Neda Hakimiha
Shima Younespour
Comparative analysis of combined methylene blue photodynamic therapy and doxorubicin treatment of oral squamous cell carcinoma cell line: In vitro study on apoptosis
Photodiagnosis and Photodynamic Therapy
Oral squamous cell carcinoma
Photodynamic therapy
Doxorubicin
Methylene blue
Apoptosis
Squamous cell carcinoma of the head and neck
title Comparative analysis of combined methylene blue photodynamic therapy and doxorubicin treatment of oral squamous cell carcinoma cell line: In vitro study on apoptosis
title_full Comparative analysis of combined methylene blue photodynamic therapy and doxorubicin treatment of oral squamous cell carcinoma cell line: In vitro study on apoptosis
title_fullStr Comparative analysis of combined methylene blue photodynamic therapy and doxorubicin treatment of oral squamous cell carcinoma cell line: In vitro study on apoptosis
title_full_unstemmed Comparative analysis of combined methylene blue photodynamic therapy and doxorubicin treatment of oral squamous cell carcinoma cell line: In vitro study on apoptosis
title_short Comparative analysis of combined methylene blue photodynamic therapy and doxorubicin treatment of oral squamous cell carcinoma cell line: In vitro study on apoptosis
title_sort comparative analysis of combined methylene blue photodynamic therapy and doxorubicin treatment of oral squamous cell carcinoma cell line in vitro study on apoptosis
topic Oral squamous cell carcinoma
Photodynamic therapy
Doxorubicin
Methylene blue
Apoptosis
Squamous cell carcinoma of the head and neck
url http://www.sciencedirect.com/science/article/pii/S1572100024004939
work_keys_str_mv AT shayanmomenigoujani comparativeanalysisofcombinedmethylenebluephotodynamictherapyanddoxorubicintreatmentoforalsquamouscellcarcinomacelllineinvitrostudyonapoptosis
AT maryamkoopaie comparativeanalysisofcombinedmethylenebluephotodynamictherapyanddoxorubicintreatmentoforalsquamouscellcarcinomacelllineinvitrostudyonapoptosis
AT fatemehamtasafarian comparativeanalysisofcombinedmethylenebluephotodynamictherapyanddoxorubicintreatmentoforalsquamouscellcarcinomacelllineinvitrostudyonapoptosis
AT nedahakimiha comparativeanalysisofcombinedmethylenebluephotodynamictherapyanddoxorubicintreatmentoforalsquamouscellcarcinomacelllineinvitrostudyonapoptosis
AT shimayounespour comparativeanalysisofcombinedmethylenebluephotodynamictherapyanddoxorubicintreatmentoforalsquamouscellcarcinomacelllineinvitrostudyonapoptosis